Stockscreener 앱 받기
1.04
2.97%
0.03
시간 외 거래:
1.04
Iridex Corp 주식(IRIX)의 최신 뉴스
Iridex CFO Romeo Dizon buys $5,004 in company stock - Investing.com
Iridex CFO Romeo Dizon buys $5,004 in company stock By Investing.com - Investing.com India
IRIDEX Corp (IRIX) CFO adds 5,004 common shares in open-market buy - Stock Titan
IRIDEX Trades Around $1 Following Holiday, Eye-Care Firm Faces Next Challenges - Bez Kabli
IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth - Yahoo Finance
IRIDEX Corporation (IRIX) Q1 2026 Earnings Surge: EPS $-0.03 vs $-0.07 ForecastGross Profit Margin - Newser
IRIDEX Corporation (NASDAQ:IRIX) Q1 2026 Earnings Call Transcript - Insider Monkey
IRIDEX Corp (IRIX) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic Growth Initiatives - GuruFocus
IRIDEX Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Iridex Beats Profit Forecasts on Cost Cuts Amidst Revenue Dip - BriefGlance
Iridex Q1 2026 Earnings Call: Complete Transcript - Benzinga
IRIDEX earnings beat by $0.02, revenue fell short of estimates - Investing.com
IRIDEX Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Is IRIDEX (IRIX) a Value Trap After Q1 2026? EPS -$0.03 Beats (e - GuruFocus
Iridex Corp (NASDAQ:IRIX) Q1 Loss Narrower Than Expected, Glaucoma Portfolio Strengthens - ChartMill
Iridex posts narrower-than-feared Q1 loss driven by cost cuts; Shares up 4% - Investing.com South Africa
Iridex Reports Q1 2026: Revenue $11.8M, Gross Profit $4.7M, Net Loss $0.5M - TradingView
IRIDEX CORP 1Q 2026: Revenue $11.8M, EPS $(0.03) — 10-Q Summary - TradingView
IRIDEX (NASDAQ: IRIX) narrows quarterly loss as margins tighten - Stock Titan
Iridex (NASDAQ: IRIX) Q1 loss narrows as 2026 outlook reaffirmed - Stock Titan
Iridex: Q1 Earnings Snapshot - marketscreener.com
Iridex Reports First Quarter 2026 Financial Results - Yahoo Finance
IRIDEX Corp stock (US4627191006): eye-care specialist draws attention after FDA clearance and strate - AD HOC NEWS
IRIDEX Corp (IRIX) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ... By GuruFocus - Investing.com Canada
IRIDEX Corp expected to post a loss of 7 cents a shareEarnings Preview - TradingView
IRIDEX Corp stock (US4627191006): Ophthalmology device maker with recent market activity - AD HOC NEWS
Earnings Preview: IRIDEX to Report Financial Results Post-market on May 19 - Moomoo
IRIDEX Corp stock (US4627191006): Recent 1.94% gain on Nasdaq - AD HOC NEWS
MSN Money - MSN
The shareholder friendly policies at IRIDEX Corporation (IRIX) | Q4 2025: EPS Beats ForecastsPro Level Trade Signals - Newser
What IRIDEX Corporation (IRIX) does that makes it resilient (Breakdown Watch) 2026-05-07Rounding Top - Newser
Iridex to Report First Quarter 2026 Financial Results on May 19, 2026 - The Manila Times
Iridex sets May 19 investor call with Q1 results after close - Stock Titan
Iridex (NASDAQ: IRIX) schedules 2026 meeting on board, pay, auditor - Stock Titan
[ARS] IRIDEX CORP SEC Filing - Stock Titan
IRIDEX Corporation (IRIX) Stock: What Affects Its Direction | Q4 2025: Profit SurprisesShort Interest - Cổng thông tin điện tử Tỉnh Sơn La
The Zacks Analyst Blog Microsoft, AbbVie, BHP, CBL & Associates Properties and IRIDEX - Zacks Investment Research
IRIDEX Corporation (IRIX) Stock Cash Trade (Breakout Watch) 2026-04-18Earnings Season - newser.com
IRIDEX Corporation (IRIX) Stock Outlook | Q4 2025: EPS Tops ViewsCatalyst Event - newser.com
Aug Reactions: Is IRIDEX Corporation forming a double bottomGDP Growth & Weekly High Return Stock Forecasts - baoquankhu1.vn
Should I Buy IRIDEX Corporation (IRIX) Stock in 2026 | Price at $1.01, Down 1.94%Small Cap Breakout - newser.com
Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology - The Manila Times
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Wondering what's happening in today's after-hours session? - ChartMill
Iridex partners with EyeProGPO for retina laser distribution - Investing.com
More than 1,800 eye care members gain pricing access to Iridex lasers - Stock Titan
IRIX Should I Buy - Intellectia AI
IRIX.O Technical Analysis & Stock Price Forecast - Intellectia AI
IRIX.O PE Ratio & Valuation, Is IRIX.O Overvalued - Intellectia AI
IRIDEX Corporation: Innovative Ophthalmic Laser Solutions for Glaucoma and Retinal Diseases - Minichart
1.27%
2.05%
자본화:
|
볼륨(24시간):